LG

■ Provides ‘Smart Case’ exclusively for the children growth failure medicine, Eutropin Pen
 □ Searched customer discomfort elements to provide solution; send injection records with a single button
 
■ Automates records to reduce children’s repulsion to treatment by preventing repeated injection on same part of the body, while making optimal diagnosis and prescription possible based on accurate records during examinations at the hospital
 
 
# “I understand that continuously recording injections helps for more effective treatment. But it’s quite troublesome to record it manually every time.” _Patient’s guardian
# “Being able to see accurate injection records will help with diagnoses and prescriptions significantly.” _Doctor
 
LG Chem will upgrade convenience in managing growth hormone injection records for children receiving growth failure treatment and their guardians.
 
On the 22nd, LG Chem announced that it will provide Smart Case that automates injection records to resolve customer inconveniences of having to manually write down growth hormone injection records every day.
 
The key to the Smart Case is that it converts the product storage case that used to be enclosed with the children’s growth failure medicine ‘Eutropin Pen’ customers to a digital format. 
 
By simply pressing the button on the case, information such as dosage, place of injection, etc. is automatically saved and recorded in the dedicated mobile app, ‘EuDi.’
 
LG Chem explained that automation of records can prevent the mistake of repeatedly injecting the same part of the body as the previous day, while doctors can check the drug compliance information of the app together with the child to make the optimal diagnosis and prescription. Forgetting where the injection was administered on the previous day, thus making the mistake of injecting the same part repeatedly can increase repulsion of children toward the treatment due to discomforts such as pain. Compliance is an index on how well the patient follows the doctor’s prescription for administering the drugs.
 
LG Chem plans to further reinforce its digital-based customer experience innovation activities starting with the supply of the Smart Case.
 
Online video education was added to the existing visit education to offer expanded injection education and consulting by professional nurses, while responding to customer inquiries around the clock by newly building an app with chatbot functions and having various information that customers might want to know about. Furthermore, it also enhanced entertainment elements such as creating characters in the app for the different growth stages meeting children at eye-level to instill positive perception on treatment.
 
A marketing staff member of LG Chem explained, “The Eutropin Pen Smart Case is an example of coming up with a solution by finding inconvenience factors experienced by customers,” while adding, “We will continuously provide distinguished customer experiences by advancing the construction of the digital ecosystem.”
 
Meanwhile, LG Chem launched Korea’s first growth hormone ‘Eutropin’ back in 1993 and it is in a firm first place in the domestic market based on its abundant clinical data, diverse lineup, etc.